Background: A comparison of the salivary microbiome of non-diabetic and diabetic cohorts having periodontal health, gingivitis and periodontitis could reveal microbial signatures unique to each group that will increase understanding of the role of oral microbiota in the pathogenesis of disease, and assist with diagnosis and risk assessment for both periodontal disease and diabetes.
significant morbidity and increased risk for mortality. 2 Periodontal disease is often more severe in T2D patients, and hyperglycemia is thought to be more severe in patients with periodontal disease. 3 Both diabetes and chronic periodontal disease have been shown to be associated with microbiome changes compared to health. 4, 5 It has been proposed that microbial dysbiosis, a concept earlier proposed in the context of the gut microbiota and inflammatory bowel disease, 6 may influence the initiation and/or progression of a variety of inflammatory states and chronic diseases. A comprehensive analysis of the oral microbiome in diabetic patients is required to better understand how the microbiota relates to both diabetes and periodontal disease status. This information may also lead to defining microbial signatures for each disease that may be useful for diagnosis and risk assessment.
Previously, several studies have reported that specific periodontal microbes are associated with diabetes. [7] [8] [9] In a recent report on the periodontal status and salivary microbiome of obese children with and without T2D, differences in salivary microbial diversity was found to be minimal between groups, with only a few differences in bacterial genus composition noted between groups. 10 Further, a literature review from 2013 concluded that diabetes does not have a significant effect on the composition of periodontal microbiota, and there is little evidence that it influences glycemic control. 11 However, conclusions drawn from studies that target select microbiota are inherently restrictive about comprehensive biofilm composition and system-level changes.
The microbiome is influenced by selective environmental pressures created by both local and systemic factors. 12 Information obtained through various omics approaches, when effectively integrated, will allow for a better system level understanding of a disease process. 13 Several studies have demonstrated changes in the oral and gut microbiome in diabetic patients. 4, 7, 14, 15 Increased levels of glucose in saliva of patients with diabetes may influence microbial diversity. 16 A recent study of salivary metabolites in patients with controlled diabetes found an increase in glucose and a significant change in markers of glycemic control and insulin resistance. 17 In participants with periodontal disease, the concentration of other selected metabolites decreased in patients with diabetes and increased in patients without diabetes. These findings suggest an interaction between diabetes and periodontal disease. Moreover, in the non-diabetic cohort with periodontal disease, concentrations of salivary metabolites increased with disease progression demonstrating a biochemical continuum. 17 To extend this metabolomics investigation using the same cohorts, the aim of the present study is to use 16S rRNA amplification sequencing to determine if a meaningful difference exists in the diversity of the salivary microbiome between participants with controlled diabetes and without diabetes with periodontal health, gingivitis, or periodontitis.
MATERIALS AND METHODS

Study population and selection criteria
This cross-sectional study, the details of which have been previously described, 17 was approved by the Institutional Review Board at the University at Buffalo and was conducted in accordance with the Helsinki Declaration. The study population included adult males and females from the Buffalo, NY area recruited over a period of 1 year. All participants provided a written informed consent before their enrollment in the study. Inclusion criteria comprised individuals between ages 18 to 65 years, in good general health or diagnosed with diabetes, and having a minimum of 20 natural teeth (excluding third molars). Individuals were excluded if they were unable or unwilling to sign the informed consent, showed a history of a medical condition that required pre-medication prior to dental visits, showed ≥5 decayed teeth, diseases of the hard or soft tissues, impaired salivary function, were exposed to antimicrobial drugs within 30 days before the first study visit, a history of uncharacterized systemic disease, were pregnant or nursing, participated in any other clinical study within 1 week before enrollment in this study, currently used tobacco products, were required to have dental treatment during the duration of the study, were immune compromised, or received periodontal treatment within the last 30 days.
Diabetes status
Diabetes status was established by self-reported history. Participants who reported a history of diabetes were asked to confirm diabetic status by providing blood samples to measure HbA1c values. An individual with T2D was defined as having HbA1c ≥ 6.5%.
Oral examination and subgroup criteria
For both the diabetic and non-diabetic cohorts, three subgroups were established: periodontal health, gingivitis, and periodontitis. Participants were stratified according to the gingivitis index, as described previously. 17 Briefly, healthy participants had an average full-mouth modified gingival index (MGI) score below 1.0, with fewer than three bleeding on probing (BOP) sites and minimal dental plaque present as scored by the method of Silness and Löe. 18 Participants with gingivitis had an average full-mouth MGI score between 1 and 2 with multiple BOP sites and periodontal pockets <4 mm. Participants with periodontitis had an average full-mouth MGI of ≥2.0 with multiple BOP sites, and 2 or more periodontal pockets with probing depths of 5 mm or more in at least two quadrants. Measurement of oral indices was performed as per Lobene et al. 19 as follows: 0 = normal, 1 = mild inflammation of the gingival unit (slight change in color, little change in texture of any portion of the gingival unit), 2 = mild inflammation of the entire gingival unit, 3 = moderate inflammation (moderate change in texture, redness, edema and hypertrophy of the gingival unit), 4 = severe inflammation (marked redness and edema/hypertrophy, spontaneous bleeding or ulceration) of the gingival unit. Plaque at any level was evaluated. Plaque indices were assessed for 6 surfaces on each tooth and the plaque index was the average of the scores obtained from all teeth. The amount of plaque observed on each tooth was scored 0 to 3 as follows: 0 = no plaque noted; 1 = plaque seen only on the tip of an explorer passed over the tooth surface; 2 = plaque obvious with the naked eye; 3 = gross deposits of plaque present over the entire tooth.
Study design and sample collection
A single dental examiner (Shannon Cervi, Department of Oral Biology, School of Dental Medicine, University at Buffalo, Buffalo, NY) evaluated all those enrolled for inclusion/exclusion criteria. Samples were collected as previously described. 17 At the first visit, to minimize the effect of toothpaste on variations in microbiota, participants received a tube of standard, non-antimicrobial fluoridated toothpaste with instructions for use. A fasting blood sample was then collected from participants self-identifying as diabetic to confirm their diabetic status. Plasma was collected by venipuncture in a sterile blood collection tube containing EDTA. At this visit, participants were given instructions for saliva collection to be obtained at the next visit within 30 days. They were to refrain from eating or drinking (excluding water) from 11:00 PM the previous evening, and to brush their teeth and entire mouth the evening before saliva donation, but not on the morning of collection. During the second visit, participants provided a completed medical history questionnaire, and answered questions to assess compliance with use of toothpaste previously provided. The oral tissues of each individual were examined to assess periodontal health status. At this visit, a minimum of 0.5 mL of unstimulated saliva was collected from each participant in a 50-mL sterile polypropylene tube, which was immediately frozen in a dry ice bath, and stored at −80 • C.
Salivary microbiome analysis
Frozen saliva samples were thawed and centrifuged at 4 • C for 15 minutes at 1500 x g. Saliva samples were processed for microbiome analysis as described previously. 10 The pellet obtained following centrifugation was re-suspended in 300 L of lysis solution (20 mg/mL lysozyme in 20 mM Tris-HCl, pH 8.0; 2 mM EDTA; 1.2% Triton X-100) and incubated at 37 • C for 1 hour. Viscous samples were dissociated by adding 20 L of 1 M DTT to 300 L of lysozyme solution, vortexed and incubated at 56 • C for 15 minutes. Salivary DNA was obtained using an automated extraction protocol. * Amplicon polymerase chain reaction (PCR) was performed for the 16S rRNA hypervariable region V3-V4 using forward V3 (5 ′ CCTACGGGNGGCWGCAG 3 ′ ) and reverse V4 primers (5 ′ GACTACHVGGGTATC-TAATCC 3 ′ ). Constructed libraries † were sequenced to obtain paired-end (2 × 300 bp) reads. ‡ The raw base call files were processed to obtain two fastq files (one each for forward and reverse reads) per sample. § DNA extraction, amplicon PCR, library construction and sequencing were performed at the genomic core facility. ¶ Paired-end fastq reads were processed using the software pipeline # as previously described. 20 Briefly, taxonomic assignments were determined by using a naive Bayesian classifier with the Human Oral Microbiome Database (HOMD) data files (version 14.5) 21 and a 98% bootstrap confidence threshold. Phylotype clustering was carried out to bin sequences and for taxonomic classification. Shared and consensus taxonomy files at various taxonomic levels and associated metadata were used for statistical analysis.
Statistical analysis
Participants (n = 143) were divided into six groups based on diabetic and periodontal health status: periodontal health and non-diabetes (C); gingivitis and non-diabetes (G); periodontitis and non-diabetes (P); periodontal health and diabetes (D); gingivitis and diabetes (DG); and periodontitis and diabetes (DP). Group comparisons for age, body mass index (BMI), and hemoglobin A1c (HbA1c) were performed using ANOVA at level 0.05. Gender differences were assessed using Fisher exact test at level 0.05.
Prior to microbiome data analysis, exploratory analysis was performed to determine outlying samples based on library size at the genus level. Participants with raw library sizes <100 (n = 3) were considered to be quantitatively inadequate and were removed from the analysis. Additionally, exploratory analysis to determine outlying operational taxonomic units (OTUs) was based on the variance of an OTU. A variance <1, or a low overall read count (< 100) across all participants or being absent (read of 0) in >100 participants were used as criteria for exclusion from differential expression analysis but were retained for alpha and beta diversity analyses. 23 A negative binomial GLM was fit to the count data and likelihood ratio tests were performed to compare abundance levels between diabetic status levels. The full GLM model included an intercept, age, BMI, an oral health status variable (0 = periodontal health, 1 = gingivitis, 2 = periodontitis), a diabetes indicator variable (0 = non-diabetic, 1 = diabetic), and an interaction between periodontal disease and diabetic status. The reduced GLM model included the intercept, age, and BMI. A likelihood ratio test was performed to compare the reduced model versus the full model for each OTU with a Benjamini-Hochberg false discovery rate (FDR) control at level 0.05 to determine significance across the family of OTUs at the genus level. 24 A dendrogram was then used to cluster the significant OTUs to determine groups of OTUs with similar patterns of significance.
T A B L E 1 Summary of clinical variables for 143 participants
The second stage used alpha diversity to assess group differences. Several measures of alpha diversity (Observed, Chao, ACE, Shannon, Simpson, Inverse Simpson) were calculated for each combination of periodontal disease progression and diabetic status. An ANOVA F-test at level 0.05 was performed to test for significant differences between the diabetic/non-diabetics, and significant differences between the periodontal disease groups.
The third stage analyzed beta diversity via the Bray-Curtis dissimilarity index. 25 Tests at level 0.05 to compare diabetes and periodontal disease status were implemented using the Multi-Response Permutation Procedure (MRPP) 26 where a non-parametric test compared the observed mean group difference to the estimated distribution of possible differences through permutations of the data. All data analyses were performed using the R programming language. Two different software packages were used to perform the differential abundance analyses * and the alpha and beta diversity analyses. †,27 * edgeR, Bioconductor software package, release 3.6 † phyloseq, R software package, The R foundation for Statistical Computing, Vienna, Austria
RESULTS
This study extended investigation of samples from previously published metabolomics investigation. 17 From a total of 174 participants originally enrolled, 146 contained sufficient quantity of DNA for microbiome analysis. Furthermore, after the microbiome data processing stage it was found that three participants had sequence read counts too low for taxonomic assignment, and therefore were removed from consideration in the statistical analysis. The final population under study thus consisted of 143 participants (n = 79 diabetics, n = 64 non-diabetics).
Comparison of clinical parameters yielded significant differences between groups in age and BMI, while no significant gender differences were noted (Table 1) . HbA1c was not significantly different between diabetic sub-groups. Accordingly, to control for differences in age and BMI, those variables were included in the reduced and full GLM models.
Stage 1 results
The microbiome OTU pruning resulted in 88 different genus level OTUs for differential abundance testing (see supplementary Table1 in online Journal of Periodontology). The likelihood ratio test for each OTU examined the significance of the oral health status variable, the diabetes status variable or their interaction. This resulted in 30 genus level OTUs that were significant when controlling the false discovery rate (FDR) at 0.05. A significant OTU indicates significant increasing or decreasing abundance when comparing groups (Healthy to Gingivitis to Periodontitis), or that there was a difference in abundance between non-diabetics or diabetics (diabetic status variable), or that there was a significantly different progression of increase or decrease in abundance in periodontal disease (healthy to gingivitis to periodontitis), compared to non-diabetics and diabetics (interaction variable). The results are summarized in a heat map of these coefficients (Figure 1) . The brightest bands (bright red or bright green) indicate significantly large coefficients for that variable.
The dendrogram results at the genus level suggest statistically significant OTUs that are largely described by two trends (Figure 1 ). Trend 1 shows OTUs that increase in abundance with increasing periodontal disease (red bands in the oral health variable), and also show increased abundance in increase/decrease in genera abundance with the progression to periodontal disease (oral health variable), and as a function of diabetes (Diabetic variable). The Interaction variable compares the change in trends of genera abundance (increase or decrease) between progression to periodontal disease (oral health variable) and diabetes (Diabetic variable). Interaction colors indicate the change in genera abundance with progressing periodontal disease relative to diabetes: zero (yellow or orange), diabetics = non-diabetics; positive (red), diabetics > non-diabetics; and negative (green) diabetics < non-diabetics. Trend 1, genera associated with increasing abundance with periodontal disease progression and larger abundance in diabetics relative to non-diabetics; Trend 2, genera associated with primarily a decrease in abundance in diabetics relative to non-diabetics diabetics relative to non-diabetics (red bands in the diabetic variable). In the interaction variable for this trend, Bifidobacterium and Abiotrophia demonstrated a decrease in abundance with progressing periodontal disease in the diabetic group (strongly green in the interaction variable). Trend 2 is driven primarily by genera that decrease in diabetics relative to nondiabetics, as shown by green bands in the diabetic variable. In this trend, Fretibacterium, Peptostreptococcaceae, Filifactor, Treponema increased in abundance with progressing periodontal disease.
Stage 2 and 3 results
Microbial diversity at the genus level, both within (alpha) and between (beta) groups were measured for each participant (n = 143). The Observed, Chao1, ACE, and Shannon metrics of alpha diversity were significant when measured by diabetes status. Overall, diabetes status was associated with lower alpha diversity (Figure 2) . Similarly, Bray-Curtis dissimilarity, the beta diversity metric used, was significant for groupings by diabetes status (P = 0.002). However, a principle coordinate analysis (PCoA) plot (Figure 3) showed clusters that differed in variance but with similar means. For periodontal disease, the Observed, Chao1, and ACE metrics where significant, indicating that alpha diversity increases with progressing periodontal disease. The beta diversity metric for oral health status was not significant (P = 0.73).
DISCUSSION
This study was undertaken to examine the salivary microbiome of participants with diabetes and various degrees of severity of periodontal disease. When the clinical variables age, BMI and gender of the cohorts were compared, diabetic cohorts were consistently older and had higher BMI than the non-diabetic cohorts (hence age and BMI were adjusted for in the modeling process). The average age of diabetic cohorts was 53 years and average BMI was 33.1. These data align with NHANES surveys (1988 to 2012) , where the largest proportion of T2D were noted in the 45 to 64 age group. Similarly, the average BMI was also comparable to previously published NHANES surveys (1988 to 2012). 28 There were no significant differences in gender between the diabetic and non-diabetic cohorts.
We compared microbiome diversity within each group (alpha diversity), and between groups (beta diversity), and by periodontal health status and diabetes status. In the exploration of OTUs by abundance at the genus level, it was noted that a distinction between diabetic and non-diabetic F I G U R E 2 Alpha diversity of microbiota. A) oral health status: A significant (P < 0.05) increase in diversity (Observed, Chao1 and ACE) was noted in the progression to periodontitis. B) diabetes: A significant (P < 0.05) decrease in diversity (Observed, Chao1, ACE, and Shannon) was noted in diabetics compared to controls. C, control; D, diabetes; G, gingivitis; P, periodontitis F I G U R E 3 Beta diversity of microbiota. A) oral health status and B) diabetes. There was a significant difference in beta diversity between diabetics and non-diabetics (P = 0.002), but not between groups by oral health status (P = 0.73). C, control; D, diabetes; G, gingivitis; P, periodontitis participants drove the largest number of significant group differences. These results, together with the previously published metabolomic data, 17 suggest that diabetes reduces the diversity of the oral microbiome. Similarly, in exploring microbiome alpha diversity, the strongest effect was imposed by diabetes status, where diabetics tended to have an overall decrease in diversity compared to non-diabetics. While the beta diversity metric was significant for groupings by diabetic status, the PCoA plot showed clusterings that were generally centralized. It is possible that the modest sample size from the same ecological environment explains the close clustering in the PCoA plot. Similarly, the significant MRPP tests might be more an indicator of the size of the clusterings rather than their location.
Oral microbiome diversity is affected by several factors. In this study, we demonstrate a significant reduction in bacterial diversity in the saliva of adult diabetics, contrary to our previous study which did not find significant differences in in adolescents with T2D and obesity compared to periodontally healthy controls. 10 These results also differ from those reported by Casarin et al., 7 who found that microbial diversity was greater in participants with diabetes compared to non-diabetic participants. This could be explained by the fact that only uncontrolled diabetic participants were studied by Casarin et al., while the diabetics in the present study were controlled by the use of medication.
Periodontal disease is characterized by destruction of the periodontium secondary to an immune response to periodontopathogenic biofilm in a susceptible host. 29 Various studies have shown that in periodontal disease, there is a significantly higher alpha diversity in periodontitis patients, supporting our findings. [30] [31] [32] Additionally, there was increased diversity in deeper periodontal pockets and the difference was statistically significant when compared to shallow sites. 33 We show in the present study an increase in diversity from health to gingivitis to periodontitis. Our results, together with Ge et al., 33 indicate that perhaps the continuum of increase is linear with progression of disease and severity. However, while the diversity was higher in periodontitis, there was less interindividual variation in periodontal disease than in healthy samples. 34 Our previous study found increased glucose concentration in the saliva of diabetic participants, 17 an environmental exposure that may alter the composition of the microbiome. Goodson et al. studied a large population of adolescents and demonstrated an overall reduction in total salivary bacterial load and in the bacterial counts of almost every species tested with increasing salivary glucose concentration. 16 Also, dysbiosis of the gut microbiome has been demonstrated in diabetic patients. 4, 14 In their seminal work on gut microbiota in obesity, Turnbaugh et al. found a reduction in microbial diversity in obesity, altered metabolic pathways and alteration in the proportion of Firmicutes to Bacteroidetes. [35] [36] [37] Here we did not see a significant alteration in the Firmicutes to Bacteroidetes ratio (data not shown) in diabetics, presumably due to the difference in ecology of oral and gastrointestinal microbiome. 38 However, we did see alterations in the salivary metabolic pathways in participants with T2D. 17 The oral cavity has one of the most diverse microbiomes when compared to other microbial niches in the human body. 38 While the oral microbiome in health is distinct, 39 there are various local and systemic factors that may play a role in shaping its diversity and composition. 40 In the present study, in Trend 1 an increased abundance of Olsenella, Mitsukella, Peptidiphaga, Bifidobacterium, Abiotrophia, Firmicutes, Veillonellaceae, Neisseriaceae, Actinobacterium, and Corynebacterium, which includes a mix of primarily anaerobic commensals and potential periodontopathogens, was found both in the progression to periodontitis and in diabetics compared to non-diabetics. When these conditions are considered together, these genera generally decreased in diabetics compared with non-diabetics with periodontitis. Interestingly, Filifactor and Treponema, genera associated with periodontal disease, were increased in relation to periodontal disease status, but not diabetes status. Trend 2 included a mix of other anaerobes that have been associated with periodontal disease. These findings suggest that the genera abundance continues to change with additional stress imposed by co-existing conditions.
These findings also raise a pertinent question: Is the composition of the salivary and subgingival plaque microbiomes similarly affected in diabetes? Traditionally, characterization of the oral microbiome of periodontal disease has been done by sampling subgingival plaque. 30, 31, 41 A study of supragingival plaque, as well as tongue scrapings and saliva samples used metagenomics and 16S rRNA sequencing for a more comprehensive characterization of the oral microbiome. 42 However, due to ease of sampling, salivary samples provide a distinctive advantage for screening purposes and have been used in various studies of health and disease. 10, 16, [43] [44] [45] [46] [47] In addition to sampling, the choice of hypervariable regions of the 16S rRNA gene that have been sequenced have an impact on characterizing the diversity of the oral microbiome. 31 Another potential limitation is lack of sample replicates within our study design and thus we are not able to assess individual variability. Also, all of the participants with diabetes in the current study had their blood glucose under control. Perhaps the addition of individuals with pre-diabetes (i.e. fasting blood sugar 100 to 125 mg/dL) may have provided an additional transitional microbial data.
CONCLUSIONS
Salivary microbiome diversity decreased in diabetics and increased with progression of periodontal disease compared to periodontally healthy controls. Select microbiota increased in both diabetes and periodontal disease but decreased in co-existing diabetes and periodontal disease. Further studies of the oral microbiome at the species level may reveal unique signatures associated with both periodontal and diabetic status.
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